Navigation Links
Maximizing Pharmaceutical Licensing Opportunities
Date:7/11/2011

os, access new technologies, and enter new geographical markets.

Cancer has emerged as the therapeutic area in which most deals are being struck. Other key therapy area targets include infectious disease, CNS disorders, metabolic/endocrine disease and auto-immune/inflammatory conditions. Rights to assets in these five therapy areas were traded in around two-thirds of all deals.

Declared financial commitments to assets licensed by the world's ten biggest pharmaceutical companies totaled more than US$78bn in the five-year period to 2010. GSK was the biggest contributor to that figure, signing deals involving up-front fees and potential milestone payments that could exceed US$19bn.

Your key questions answered

* Why do a growing number of Big Pharma CEOs favor licensing and alliance deals over M&A transactions?

* How do leading multinationals structure their licensing activities, and how are approaches changing?

* What factors lie behind the recent upturn in deal-making volumes, and will the increase be sustained?

* Which therapy areas are the subject of most licensing deals?

* Which companies top the Big Pharma licensing league in terms of deal volumes and financial commitments?

Executive Summary

Pharmaceutical licensing

Pharmaceutical licensing trends

Big Pharma licensing profiles

Future trends in pharma licensing

About the author

Disclaimer

Pharmaceutical licensing

Summary

Introduction

Mega-trends behind the pharma licensing boom

An industry in flux

Looking out, not in

Licensing

Licensing versus M&A

Goals and targets

Procedures and approaches

Pharmaceutical licensing trends

Summary

Introduction

Deal volumes

The deal-making community

Licensing targets

Deal values

Up-front payments

Milestone payments

Big Pharma li
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioInformatics, LLC New Market Report - Life Science Instruments: Maximizing Market Share
2. Maximizing the Potential of Internal and External Communications Groups
3. Maximizing the Potential of Multi-Drug Portfolios without Undermining a Legacy Brand
4. PAREXEL Expert Serves as Lead Author and Editor of Definitive Resource on Quality by Design (QbD), Aimed at Maximizing Product Quality and Speeding Treatments to Market
5. Maximizing the Potential of Multi-Drug Portfolios Without Cannibalizing from a Legacy Brand
6. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
7. Valeant Pharmaceuticals Agrees to Acquire Dermik
8. HUYA BIOSCIENCE INTERNATIONAL ENGAGES IN PARTNERSHIP WITH LIAONING (BENXI) BIO-PHARMACEUTICAL INDUSTRY BASE
9. Par Pharmaceutical Companies to Report Second Quarter 2011 Results on August 3, 2011
10. JHP Pharmaceuticals Launches New Multipack Presentations of Adrenalin®, Coly-Mycin® M and Pitocin®
11. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013 Velplex, LLC announced this week that ... that connects buyers and sellers of discount dental ... Why? It,s because the business leaders ... with the dental industry. They have 50 years of ... worked to negotiate some of the best prices in ...
(Date:6/17/2013)... , June 17, 2013 Vanda ... presented additional data today at ENDO 2013, the ... that tasimelteon can entrain (synchronize) both melatonin and ... to reset the master body clock and address ... Disorder (Non-24).  The SET (Safety and Efficacy of ...
(Date:6/17/2013)...  Hanger, Inc. (NYSE:  HGR) today announced the signing ... senior secured facilities to an aggregate of up to ... agreement includes a $200 million revolving credit facility and ... agreement was comprised of a $100 million revolving credit ... facility matures on June 17, 2018, and is subject ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... has received U.S. Food and Drug Administration ("FDA") ... for Enoxaparin Sodium Injection in the 100mg/mL and ... equivalent to Sanofi-aventis, LOVENOX®, and is a low ...
... SYDNEY, Sept. 19, 2011 HeartWare International, Inc. (NASDAQ: ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that CEO Doug Godshall is scheduled to present ... Device Day at 1:55 p.m. ET on Thursday, September ...
Cached Medicine Technology:Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R) 2Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R) 3HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day 2
(Date:6/17/2013)... Tempe, AZ (PRWEB) June 17, 2013 Bust’DD ... are both stylish and well-fitting to women with large busts, ... is founded by two women who understand the problem of ... to other busty women. Their goal is to raise at ... end goal of offering their bras on a wide scale. ...
(Date:6/17/2013)... CA (PRWEB) June 17, 2013 The ... announce a new series of reports highlighting how sustainable ... challenge of growing populations and their demand on food ... an independently produced television series airing in markets around ... by the legendary Martin Sheen, who is marking the ...
(Date:6/17/2013)... 17, 2013 As da Vinci robot ... the country, Bernstein Liebhard LLP notes that a recent report ... some of the disturbing robotic surgery complications alleged to have ... other things, the June 14th broadcast revealed that the U.S. ... reports of da Vinci patients who suffered burns, cuts and ...
(Date:6/17/2013)... City Beach, FL (PRWEB) June 17, 2013 ... higher purpose--fighting hunger. Oceana Naturals LLC, the US distributor ... region of The Bay Area Food Bank ... families, and struggling seniors by seeing that they receive ... Natural Sunscreen and All Natural Moisturizer. Contributions will ...
(Date:6/17/2013)... TX (PRWEB) June 17, 2013 ... to announce that they are now open in ... communities neurofeedback treatments, counseling and access to educational ... that can be used to help with athletic ... Director of the center, Cheryl Camarillo, LCSW, works ...
Breaking Medicine News(10 mins):Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 3Health News:All Natural Sunscreen Fights Hunger 2Health News:Professional Center for Enhanced Performance Opens in Schertz 2
... Brain State,Technologies(TM), ( http://www.brainstatetech.com ) along with its,participating ... soldiers from Iraq and Afghanistan. The VA ... in the last year.,According to the VA, more ... from Mental Health disorders, and more than 16,000 ...
... AMERIGROUP,Corporation (NYSE: AGP ) today announced that ... the sale of its assets,including TLC Family Care Health ... approval by the State of Tennessee. The,transaction is expected ... TLC Family Care Health Plan serves about 167,000 low-income ...
... letter sent today,the Foundation for Taxpayer and Consumer Rights ... answer seven questions about,the details of their reported compromise ... even though there are only a few days remaining,in ... FTCR wrote: "Nearly all Californians embrace reform and ...
... Acquisition Corp.,(OTC Bulletin Board: PMQC, PMQCU, PMQCW), a ... has expanded into the Albany, New,York market by ... care,pharmacy from an affiliate of Eden Park Health ... consummated on August 27, 2007, Chem Rx,assumed the ...
... ("Concentra" or the,"Company"), a national leader in on-site ... of medical services and general wellness programs.,Horizon Air, ... known for its,safe, reliable air transportation with caring, ... for an on-site health program that,matched its commitment ...
... Sept. 5 Caraco Pharmaceutical,Laboratories, Ltd., (Amex: ... and Drug,Administration (FDA) has granted final approval for ... Tablets, 3.125 mg,6.25 mg, 12.5 mg and 25 ... agent indicated for the,treatment of left ventricular dysfunction ...
Cached Medicine News:Health News:AMERIGROUP to Acquire Memphis Health Plan 2Health News:AMERIGROUP to Acquire Memphis Health Plan 3Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 2Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 3Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 4Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 5Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 6Health News:Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market 2Health News:Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market 3Health News:Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market 4Health News:Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market 5Health News:Concentra Expands Horizon Air Employee Health Program With On-Site Clinic 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R) 2
... The model 55S Rocking Shaker provides ... and blotted membranes. The very slow ... degree of tilt provide a gentle ... over gels and blotted membranes to ...
Plate Roller...
Conversion Kits For Modular Incubator Chamber...
Multi-Tier Shaker...
Medicine Products: